로딩 중…
StockDiggingStockDigging

Seoulin Bioscience Co.,Ltd.

038070· KOSDAQ
₩4,950-1.39%
2026-06-19

Price Chart

Seoulin Bioscience Co.,Ltd.-36.17%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap46.04B KRW
Revenue78.58B KRW
Net Income-581.2M KRW
Total Assets119.42B KRW
Net Assets85.34B KRW
Employees110
Value
P/B0.54x
P/S0.59x
EV/EBITDA213.63x
Profitability
ROE-0.68%
ROA-0.49%
Op. Margin0.28%
Revenue Growth8.28%
Earnings Growth-59.83%
Financial Health
Debt Ratio139.93%
Total Debt11.76B KRW
Cash10.85B KRW
Current Ratio2.23x
Net Debt/EBITDA4.13x
Dividend
Div. Yield1.95%
Div. Growth0.00%
Performance
1Y Return-36.17%
1M Return-13.76%
From 52W High-42.95%
1Y MDD-41.33%
Trading
Volume64,174 shares
Foreign Own.3.10%
Per Share
EPS56 KRW
BPS9,461 KRW

Company Info

CEO 황을문, 강미옥 (각자 대표이사)
Employees 110
Founded 1994
HQ 경기도 성남시, KR

SEORIN BIO, founded in 1984, converted to a corporation in 1994, and listed on KOSDAQ in 2005, is a specialized bio company. It provides raw and subsidiary materials for biopharmaceuticals and reagents/equipment for basic life science research, offering total solutions across the bio industry with over 58,000 items. The company supplies core raw materials like cell culture media through global partnerships and supports customer R&D with its industry experience and cold chain logistics infrastructure. SEORIN BIO is headquartered in Seongnam-si, Gyeonggi-do.